Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms

Permanent link
https://hdl.handle.net/10037/19491
DOI
https://doi.org/10.1200/GO.20.00346
Thumbnail
View/Open
Published version (PDF)
Date
2020-09-08
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Author
saini, kamal; de las Heras, Begona; Plummer, Ruth; Moreno, Victor; Romano, Marco; de Castro, Javier Mayor; Aftimos, Philippe; Fredriksson, Judy; Bhattacharyya, Gouri Shankar; Olivo, Martin Sebastian; Schiavon, Gaia; Punie, Kevin; Garcia-Foncillas, Jesus; Rogata, Ernesto; Pfeiffer, Richie; Orbegosa, Cecilia; Morrison, Kenneth; Curigliano, Giuseppe; Chin, Lynda; Saini, Monika Lamba; Rekdal, Øystein; Anderson, Steven; Cortes, Javier; Leone, Manuela; Dancey, Janet; Twelves, Chris; Awada, Ahmad
Abstract
The process of developing new anticancer therapeutics has been considered by some to be expensive, time consuming, bureaucratic, and, to some extent, inefficient. The coronavirus disease 2019 (COVID-19) pandemic has significantly affected clinical oncology studies and underlined the need to embrace and accelerate long-pending and awaited reforms to cancer clinical trial methodology.

This article highlights the need for optimal use of technology, reduced paperwork and bureaucracy, speedier trial setup, and greater patient centricity in the design and conduct of future clinical and translational cancer studies around the world.

Publisher
American Society of Clinical Oncology
Citation
saini, de las Heras, Plummer R, Moreno V, Romano, de Castro JM, Aftimos, Fredriksson, Bhattacharyya, Olivo, Schiavon, Punie, Garcia-Foncillas, Rogata, Pfeiffer, Orbegosa, Morrison K, Curigliano G, Chin, Saini, Rekdal Ø, Anderson, Cortes J, Leone, Dancey, Twelves, Awada A. Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms. Journal of Global Oncology (JGO). 2020;6:1357-1362
Metadata
Show full item record
Collections
© 2020 by American Society of Clinical Oncology